Bone Morphogenic Protein-7 (BMP-7) Polymorphism: Susceptibility to Cirrhosis and Hepatocellular Carcinoma After Viral Hepatitis in Egyptian Patients

Overview

Journal Clin Exp Hepatol

Specialty Gastroenterology

Date 2023 Jul 28

PMID 37502432

Authors

Hind S AboShabaan

Osama Alghannam

Faisal Ismail

Islam M El-Garawani

Mohamed El-Shahat

Roba M Talaat

Eman A El-Maadawy

Nasser Hussein

Zeinab A Kasemy

Eman Abdelsameea

Soghra Haq

Heba M Hathout

Affiliations

Soon will be listed here.

Abstract

Aim Of The Study: Bone morphogenic proteins (BMPs) have both inhibitory and stimulatory effects on growth of a tumor that depend on the type of cells, the dosage and the tumor microenvironment. We aimed to investigate the impact of the bone morphogenic protein-7 (BMP-7) single nucleotide polymorphism (SNP) rs230205 [A/G] on susceptibility to hepatocellular carcinoma (HCC) progression from liver cirrhosis after viral hepatitis infection in Egyptian patients.

Material And Methods: The amplification-refractory mutation system (ARMS)-polymerase chain reaction (PCR) method was used to genotype the rs230205 [A/G] SNP in 150 subjects (50 patients with post-hepatitis C or B cirrhosis, 50 HCC patients, and 50 controls). Expression level of BMP-7 protein was assessed using enzyme-linked immunosorbent assay (ELISA).

Results: The results revealed insignificant changes in distribution of all genotypes/alleles of the BMP-7 rs230205 [A/G] SNP between cirrhotic patients, HCC patients and controls. The AA genotype and A allele could be considered risk factors for cirrhosis (OR = 1.75, 1.50) and HCC (OR = 2.19, 1.74), respectively. The AA genotype (95% CI: 0.45-6.79) and A allele (OR = 1.50, 95% CI: 0.77-2.93) may be viewed as cirrhosis risk factors based on group segregation. Additionally, the A allele, AG and AA genotypes and their combined ORs of 2.19 (95% CI: 0.58-8.23), 1.74 (95% CI: 0.90-3.37), and 1.70 (95% CI: 0.68-4.29) could all be risk factors for HCC. No genotype or allele could be regarded as a risk factor for progression of cirrhosis to HCC, according to OR values.

Conclusions: The results showed no correlation between BMP-7 rs230205 [A/G] SNP and progression of cirrhosis to HCC. To confirm our findings, additional prospective large-scale research is required.

References

Tacke F, Gabele E, Bataille F, Schwabe R, Hellerbrand C, Klebl F . Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci. 2007; 52(12):3404-15. DOI: 10.1007/s10620-007-9758-8. View

Demir N, Kolgelier S, Inkaya A, Sumer S, Demir L, Pehlivan F . Are bone morphogenetic protein-7 (BMP-7) serum levels correlated with development of hepatic fibrosis?. J Infect Dev Ctries. 2014; 8(5):605-10. DOI: 10.3855/jidc.4033. View

Wei S, Sun Y, Wang L, Zhang T, Hu W, Bao W . Hyperoside suppresses BMP-7-dependent PI3K/AKT pathway in human hepatocellular carcinoma cells. Ann Transl Med. 2021; 9(15):1233. PMC: 8421975. DOI: 10.21037/atm-21-2980. View

Weiskirchen R, Meurer S . Bone morphogenetic protein-7 in focus: a member of the transforming growth factor-beta superfamily is implicated in the maintenance of liver health. Hepatology. 2007; 45(5):1324-5. DOI: 10.1002/hep.21694. View

Zheng Y, Wang X, Wang H, Yan W, Zhang Q, Chang X . Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway. Tumour Biol. 2014; 35(6):5189-98. DOI: 10.1007/s13277-014-1673-y. View

Wang L, Dong J, Xiong L, Shi K, Zou Z, Zhang S . BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor. Int J Clin Exp Pathol. 2014; 7(7):3537-47. PMC: 4128967. View

Gao L, Li S, Shao C, Fu W, Liu Y, He J . BMP7 gene polymorphisms are not associated with bone mineral density or osteoporotic fractures in postmenopausal Chinese women. Acta Pharmacol Sin. 2016; 37(8):1076-82. PMC: 4973379. DOI: 10.1038/aps.2016.28. View

Nishinakamura R, Sakaguchi M . BMP signaling and its modifiers in kidney development. Pediatr Nephrol. 2013; 29(4):681-6. DOI: 10.1007/s00467-013-2671-9. View

El-Nabi S, Sayed S, Abd-Elhafez M, Elfiky M, Abdel Moneim A, El-Garawani I . Arg753Gln Polymorphisms in the Toll-Like Receptor 2 Gene are Associated with Cytomegalovirus Infection in Egyptian Bone Marrow Recipients. Endocr Metab Immune Disord Drug Targets. 2019; 20(4):619-624. DOI: 10.2174/1871530319666191018124710. View

10.

El-Garawani I, Shaheen E, El-Seedi H, Khalifa S, Mersal G, Emara M . Angiotensinogen Gene Missense Polymorphisms (rs699 and rs4762): The Association of End-Stage Renal Failure Risk with Type 2 Diabetes and Hypertension in Egyptians. Genes (Basel). 2021; 12(3). PMC: 7996594. DOI: 10.3390/genes12030339. View

11.

Aluganti Narasimhulu C, Singla D . The Role of Bone Morphogenetic Protein 7 (BMP-7) in Inflammation in Heart Diseases. Cells. 2020; 9(2). PMC: 7073173. DOI: 10.3390/cells9020280. View

12.

El-Garawani I, El-Nabi S, Gadallah M, Abdelsameea E . Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients. Immunol Invest. 2020; 50(1):12-22. DOI: 10.1080/08820139.2020.1722158. View

13.

Cervantes-Garcia D, Cuellar-Juarez A, Borrego-Soto G, Rojas-Martinez A, Aldaba-Muruato L, Salinas E . Adenoviral‑bone morphogenetic protein‑7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model. Mol Med Rep. 2017; 16(6):9431-9440. PMC: 5780000. DOI: 10.3892/mmr.2017.7785. View

14.

Hanouneh I, Alkhouri N, Singal A . Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?. Clin Mol Hepatol. 2019; 25(3):264-269. PMC: 6759429. DOI: 10.3350/cmh.2019.1001. View

15.

Zou G, Zuo S, Lu S, Hu R, Lu Y, Yang J . Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis regulation of TGF-β/Smad signaling pathway. World J Gastroenterol. 2019; 25(30):4222-4234. PMC: 6700693. DOI: 10.3748/wjg.v25.i30.4222. View

16.

Ji X, Jin S, Qu X, Li K, Wang H, He H . Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression. BMC Cancer. 2015; 15:801. PMC: 4624178. DOI: 10.1186/s12885-015-1798-4. View

17.

Yang J . Detect or not to detect very early stage hepatocellular carcinoma? The western perspective. Clin Mol Hepatol. 2019; 25(4):335-343. PMC: 6933123. DOI: 10.3350/cmh.2019.0010. View

18.

Hou F, Liu R, Liu X, Cui L, Wen Y, Yan S . Attenuation of liver fibrosis by herbal compound 861 via upregulation of BMP-7/Smad signaling in the bile duct ligation model rat. Mol Med Rep. 2016; 13(5):4335-42. DOI: 10.3892/mmr.2016.5071. View

19.

Cho K, Kim N, Seo S, Song S, Jeong C, Kim H . A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- signaling. Am J Cancer Res. 2022; 12(2):763-778. PMC: 8900005. View

20.

Wang L, Ding Q, Zhao L, Pan Y, Song Z, Qin Y . Decreased BMP-7 and p-Smad1/5/8 expression, and increased levels of gremlin in hepatocellular carcinoma. Oncol Lett. 2018; 16(2):2113-2118. PMC: 6036485. DOI: 10.3892/ol.2018.8918. View